Literature DB >> 12176818

Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis.

F Soliotis, M Glover, A S M Jawad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176818      PMCID: PMC1754223          DOI: 10.1136/ard.61.9.850

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  A case of cellulitis causing tissue defect during etanercept therapy.

Authors:  Dulgeroglu Deniz; Umay Ebru; Bal Ajda; Tetik Menevse Gulsum; Tatlican Semih; Cakci Aytul
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 3.  Leflunomide: friend or foe for systemic lupus erythematosus?

Authors:  Guo-Cui Wu; Xiao-Di Xu; Qiong Huang; Hua Wu
Journal:  Rheumatol Int       Date:  2012-09-08       Impact factor: 2.631

4.  Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions.

Authors:  K M J Douglas; E Ladoyanni; G J Treharne; E D Hale; N Erb; G D Kitas
Journal:  Ann Rheum Dis       Date:  2006-02-13       Impact factor: 19.103

Review 5.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

6.  Acute generalized exanthematous pustulosis induced by etanercept: another dermatologic adverse effect.

Authors:  Mukaddes Kavala; Ilkin Zindancı; Zafer Türkoglu; Burçe Can; Emek Kocatürk; Serkan Senol; Filiz Topaloglu
Journal:  Case Rep Dermatol Med       Date:  2013-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.